Association of Epicardial Adipose Tissue with Novel Inflammation and Heart Failure Biomarkers in Type 2 Diabetes Patients : Effect of Metabolic Control
Gil, Pedro (Universitat Autònoma de Barcelona. Departament de Medicina)
Rives Jimenez, Jose (Institut de Recerca Sant Pau)
Viladés Medel, David (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
García Osuna, Álvaro (Institut de Recerca Sant Pau)
Genua, Idoia (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Miñambres, Inka (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Grau-Agramunt, Margarita (Institut de Recerca Sant Pau)
Gich, Ignasi (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Camacho, Mercedes (Institut de Recerca Sant Pau)
Benitez, Sonia (Institut de Recerca Sant Pau)
Julve i Gil, Josep (Institut de Recerca Sant Pau)
Sanchez-Quesada, Jose Luis (Institut de Recerca Sant Pau)
Pérez Pérez, Antonio (Universitat Autònoma de Barcelona. Departament de Medicina)

Date:	2025
Abstract:	Background : Type 2 diabetes (T2D patients) have a 74% increased risk of heart failure (HF), but traditional HF biomarkers lack sensitivity in early disease detection. Increased epicardial adipose tissue volume (EATv) is associated with cardiovascular risk in T2D, and novel biomarkers such as growth differentiation factor 15 (GDF15), Galectin-3, and soluble suppression of tumorigenicity 2 (sST2) are inflammation biomarkers linked to HF. Methods : We investigated associations between EATv, inflammation biomarkers, and the effect of metabolic control in 14 healthy controls (HCs) and 36 newly diagnosed T2D patients both before (poor glycemic control, PGC) and after 12 months of glycemic optimization (good glycemic control, GGC). EATv indexed to body surface area (iEATv) was quantified by multidetector computed tomography, and biomarker levels were measured by immunoassays. Results : PGC patients had higher iEATv (59. 53 ± 21. 67 vs. 36. 84 ± 16. 57 cm 3 /m 2, p = 0. 0017) and elevated GDF15, Galectin-3, and sST2 levels (all p < 0. 05) than HC subjects. The glycemic optimization reduced iEATv (p = 0. 0232) and sST2 (p = 0. 048), while GDF15 and Galectin-3 remained unchanged. Multivariable analysis confirmed independent associations between iEATv, GDF15 (β = 0. 27, p = 0. 027) and sST2 (β = 0. 29, p = 0. 02). Conclusions : These results support the link between systemic inflammation, EAT expansion, and cardiac dysfunction, and they point to the role of epicardial fat in early HF risk of T2D patients.
Grants:	Ministerio de Economía y Competitividad PI16/00471 Instituto de Salud Carlos III PI17/00232 Instituto de Salud Carlos III PI20/00334 Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-01149
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Epicardial adipose tissue (EAT) ; Type 2 diabetes (T2D) ; Cardiovascular risk ; Heart failure (HF) ; Inflammatory biomarkers ; GDF15 ; Galectin-3 ; Sst2 ; Metabolic control (MC)
Published in:	Journal of clinical medicine, Vol. 14 Núm. 13 (July 2025) , ISSN 2077-0383

DOI: 10.3390/jcm14134687
PMID: 40649060

14 p, 539.5 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles